CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Update

CanSino Biologics Inc. (OTCMKTS:CASBFGet Free Report) was the recipient of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 13,400 shares, a decline of 8.2% from the January 15th total of 14,600 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 134.0 days.

CanSino Biologics Price Performance

Shares of CASBF opened at C$3.37 on Wednesday. The firm’s fifty day simple moving average is C$3.67 and its two-hundred day simple moving average is C$3.28. CanSino Biologics has a 12 month low of C$1.86 and a 12 month high of C$4.35.

CanSino Biologics Company Profile

(Get Free Report)

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.

Read More

Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.